171 related articles for article (PubMed ID: 31733633)
1. Imbalance between Fibrin Clot Formation and Fibrinolysis Predicts Cardiovascular Events in Patients with Stable Coronary Artery Disease.
Neergaard-Petersen S; Larsen SB; Grove EL; Kristensen SD; Ajjan RA; Hvas AM
Thromb Haemost; 2020 Jan; 120(1):75-82. PubMed ID: 31733633
[TBL] [Abstract][Full Text] [Related]
2. The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease.
Neergaard-Petersen S; Hvas AM; Kristensen SD; Grove EL; Larsen SB; Phoenix F; Kurdee Z; Grant PJ; Ajjan RA
Thromb Haemost; 2014 Dec; 112(6):1142-50. PubMed ID: 25187394
[TBL] [Abstract][Full Text] [Related]
3. Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure.
Neergaard-Petersen S; Ajjan R; Hvas AM; Hess K; Larsen SB; Kristensen SD; Grove EL
PLoS One; 2013; 8(8):e71150. PubMed ID: 23976993
[TBL] [Abstract][Full Text] [Related]
4. Impaired Fibrinolysis Predicts Adverse Outcome in Acute Coronary Syndrome Patients with Diabetes: A PLATO Sub-Study.
Sumaya W; Wallentin L; James SK; Siegbahn A; Gabrysch K; Himmelmann A; Ajjan RA; Storey RF
Thromb Haemost; 2020 Mar; 120(3):412-422. PubMed ID: 31975352
[TBL] [Abstract][Full Text] [Related]
5. The ABO Locus is Associated with Increased Fibrin Network Formation in Patients with Stable Coronary Artery Disease.
Winther-Larsen A; Christiansen MK; Larsen SB; Nyegaard M; Neergaard-Petersen S; Ajjan RA; Würtz M; Grove EL; Jensen HK; Kristensen SD; Hvas AM
Thromb Haemost; 2020 Sep; 120(9):1248-1256. PubMed ID: 32604426
[TBL] [Abstract][Full Text] [Related]
6. Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy.
Sumaya W; Wallentin L; James SK; Siegbahn A; Gabrysch K; Bertilsson M; Himmelmann A; Ajjan RA; Storey RF
Eur Heart J; 2018 Apr; 39(13):1078-1085. PubMed ID: 29390064
[TBL] [Abstract][Full Text] [Related]
7. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects.
Undas A; Brozek J; Jankowski M; Siudak Z; Szczeklik A; Jakubowski H
Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1397-404. PubMed ID: 16574890
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine thiolactone contributes to the prognostic value of fibrin clot structure/function in coronary artery disease.
Sikora M; Skrzydlewski P; Perła-Kaján J; Jakubowski H
PLoS One; 2022; 17(10):e0275956. PubMed ID: 36301961
[TBL] [Abstract][Full Text] [Related]
10. Impaired fibrin clot lysis is associated with increased mortality in patients after coronary artery bypass grafting: A long-term follow-up study.
Gołąb A; Plicner D; Wypasek E; Natorska J; Kapelak B; Plens K; Undas A
Eur J Clin Invest; 2022 Jul; 52(7):e13775. PubMed ID: 35313018
[TBL] [Abstract][Full Text] [Related]
11. Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long-term follow-up study.
Bryk AH; Konieczyńska M; Polak M; Plicner D; Bochenek M; Undas A
Cardiovasc Diabetol; 2021 Feb; 20(1):47. PubMed ID: 33602240
[TBL] [Abstract][Full Text] [Related]
12. Elevated factor XIa as a modulator of plasma fibrin clot properties in coronary artery disease.
Paszek E; Malinowski KP; Ząbczyk M; Butenas S; Undas A
Eur J Clin Invest; 2023 Sep; 53(9):e14007. PubMed ID: 37042848
[TBL] [Abstract][Full Text] [Related]
13. Factor XIII Val34Leu polymorphism and recurrent myocardial infarction in patients with coronary artery disease.
Kreutz RP; Bitar A; Owens J; Desta Z; Breall JA; von der Lohe E; Sinha A; Vatta M; Nystrom P; Jin Y; Flockhart DA
J Thromb Thrombolysis; 2014 Oct; 38(3):380-7. PubMed ID: 24510702
[TBL] [Abstract][Full Text] [Related]
14. Interpretation and Validation of Maximum Absorbance Data Obtained from Turbidimetry Analysis of Plasma Clots.
Pieters M; Guthold M; Nunes CM; de Lange Z
Thromb Haemost; 2020 Jan; 120(1):44-54. PubMed ID: 31752041
[TBL] [Abstract][Full Text] [Related]
15. Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality.
Undas A; Kolarz M; Kopeć G; Tracz W
Nephrol Dial Transplant; 2008 Jun; 23(6):2010-5. PubMed ID: 18156458
[TBL] [Abstract][Full Text] [Related]
16. Reduced Plasma Magnesium Levels in Type-1 Diabetes Associate with Prothrombotic Changes in Fibrin Clotting and Fibrinolysis.
Sobczak AIS; Phoenix FA; Pitt SJ; Ajjan RA; Stewart AJ
Thromb Haemost; 2020 Feb; 120(2):243-252. PubMed ID: 31942750
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of clot density, fibrin fiber radius, and protofibril packing in acute phase myocardial infarction.
Siniarski A; Baker SR; Duval C; Malinowski KP; Gajos G; Nessler J; Ariëns RAS
Thromb Res; 2021 Sep; 205():110-119. PubMed ID: 34298252
[TBL] [Abstract][Full Text] [Related]
18. Aspirin therapy is associated with less compact fibrin networks and enhanced fibrinolysis in patients with abdominal aortic aneurysm.
Bailey MA; Aggarwal R; Bridge KI; Griffin KJ; Iqbal F; Phoenix F; Purdell-Lewis J; Thomas T; Johnson AB; Ariëns RA; Scott DJ; Ajjan RA
J Thromb Haemost; 2015 May; 13(5):795-801. PubMed ID: 25660763
[TBL] [Abstract][Full Text] [Related]
19. Fibrin clot formation and fibrinolysis in patients with a history of coronary stent thrombosis.
Godschalk TC; Konings J; Govers-Riemslag JW; Ten Berg JM; Hackeng CM; Ten Cate H
Thromb Res; 2016 Jul; 143():58-62. PubMed ID: 27191854
[TBL] [Abstract][Full Text] [Related]
20. Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetes.
Konieczyńska M; Bryk AH; Malinowski KP; Draga K; Undas A
Thromb Haemost; 2017 Aug; 117(9):1671-1678. PubMed ID: 28569923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
